Security key
457637601
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 132,993
- Total 13F value
- $876,125
- Share change
- +132,993
- SEC-reported price per share
- $6.58
- Number of holders
- 8
- Value change
- +$876,125
- Number of buys
- 8
- Shares outstanding
- 804,525
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
8
Top holders
8
INM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 457637601
Recent filing periods:
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
8/12
Latest evidence
30 Jun 2022
13F
3/4/5
Lead comparable stake: 130%
4 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 130%.
8 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
130%
RENAISSANCE TECHNOLOGIES LLC
6.7%
TWO SIGMA ADVISERS, LP
6.5%
GEODE CAPITAL MANAGEMENT, LLC
1.9%
CITADEL ADVISORS LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
130%
|
$450,000
956,118 shares
|
— | 30 Jun 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
6.7%
|
$23,000
49,700 shares
|
— | 30 Jun 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
6.5%
|
$23,000
48,281 shares
|
— | 30 Jun 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.9%
|
$6,000
13,905 shares
|
— | 30 Jun 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.8%
|
$6,000
12,966 shares
|
— | 30 Jun 2022 |
| Creative Planning |
13F
Company
|
1.5%
|
$5,000
10,832 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
132,993
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q4 2024 Across Filers
Q4 2024 holders
0
Q3 2022 holders
8
Holder diff
8
| Investor | Q4 2024 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q4 2024 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend